CVS Health Corp vs Twilio Inc — how do they compare? CVS Health Corp trades at $93.65 (market cap $122.36B), while Twilio Inc trades at $255.3 (market cap $38.40B). The key difference: CVS Health Corp is far larger — about 3.2× Twilio Inc's market cap, and CVS Health Corp pays a 2.78% dividend while Twilio Inc pays none. Which is the better fit depends on your goals.
| CVS | TWLO | |
|---|---|---|
Market Cap | $122.36B | $38.40B |
Sector | Health | Technology |
52-Week High | $110.60 | $255.95 |
52-Week Low | $65.51 | $95.23 |
Enterprise Value | $184.71B | $36.81B |
Dividend Yield | 2.78% | — |
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $95.70, down 0.54% on the day, with a bearish technical signal and key support at $95. The company reported strong Q2 2026 earnings, beating estimates with EPS of $2.58 versus $1.87 expected, and raised its full-year guidance. Revenue growth remains robust, reaching $402.07 billion in 2025, though net income margin compressed to 1.18%. Analyst sentiment is overwhelmingly positive with a consensus price target of $115.00.
The outlook for CVS is cautiously optimistic, driven by operational improvements in its Aetna segment and raised cash flow guidance. Investment opportunities include potential upside to the consensus target, but risks involve margin pressures, regulatory changes impacting pharmacy benefits in 2027, and high debt levels. The stock's current valuation at a P/E of 25.25 may limit near-term gains if earnings growth slows.
Twilio (TWLO) trades at $241.28, up 24.89% in 24 hours, near its 52-week high. The stock is in a bullish technical trend with strong support at $228 and resistance at $255. Recent Q2 2026 earnings beat expectations with EPS of $1.47 versus $1.32 expected, and revenue grew 22% year-over-year to $1.5 billion. The company raised full-year 2026 revenue growth guidance to 18%-18.5%.
The outlook is positive with accelerating revenue growth and improving profitability, but risks include high valuation multiples and reliance on continued execution. Analyst consensus is strongly bullish with a $266.31 price target, though the stock's rapid ascent warrants caution near-term.
Trailing returns across standard periods
Latest headlines on both assets
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →Twilio Inc. is a cloud-based communication platform-as-a-service company offering communication building blocks that allow for a fully customized customer engagement experience spanning voice, video, chat, and SMS messaging. It does this through various application programming interfaces, or APIs, and prebuilt solution applications aimed at improving customer engagement. The company leverages its Super Network, a global network of carrier relationships, to facilitate high-speed, cost-effective communication.
Read more on TWLO →